SOCS1 and Its Potential Clinical Role in Tumor

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2019 Feb 15

PMID 30761449

Citations 20

Authors

Jie Ying

Xiaoyan Qiu

Yu Lu

Miaomiao Zhang

Affiliations

Soon will be listed here.

Abstract

Suppressor of cytokine signaling1 (SOCS1), as a member of SOCS family, has been widely studied in recent years. It has been found that SOCS1 not only participates in cell signaling, but also in ubiquitination mediated protein degradation process. Both of these two functions play an important role in the growth and proliferation of cells. Therefore, researchers speculated that SOCS1 also played an important role in tumors. This review mainly focuses on the structure, transcriptional regulation and functions of SOCS1 protein, and finally describes the possible clinical role of SOCS1 protein in tumors.

Citing Articles

SOCS1: A potential diagnostic and prognostic marker for aggressive gliomas and a new target for immunotherapy.

Gu C, Chen X, Wu J, Zhang Y, Zhong L, Luo H Medicine (Baltimore). 2024; 103(49):e40632.

PMID: 39654174 PMC: 11630960. DOI: 10.1097/MD.0000000000040632.

Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma.

Sayed Amr K, Mohamed Ezzat W, Ibrahim Saleh A, Heiba A, Amin H, Refaat Kamel R J Genet Eng Biotechnol. 2024; 22(3):100394.

PMID: 39179317 PMC: 11214395. DOI: 10.1016/j.jgeb.2024.100394.

SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.

Morelli M, Madonna S, Albanesi C Front Immunol. 2024; 15:1393799.

PMID: 38975347 PMC: 11224294. DOI: 10.3389/fimmu.2024.1393799.

TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1.

Yu C, Wang J, Li Y Biochem Genet. 2024; .

PMID: 38918306 DOI: 10.1007/s10528-024-10865-8.

-Regulated Signaling Pathways in Breast Cancer Progression.

Capela A, Tavares-Marcos C, Estima-Arede H, Nobrega-Pereira S, de Jesus B Cancers (Basel). 2024; 16(3).

PMID: 38339387 PMC: 10854850. DOI: 10.3390/cancers16030636.

References

De Sepulveda P, Ilangumaran S, Rottapel R . Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J Biol Chem. 2000; 275(19):14005-8. DOI: 10.1074/jbc.c000106200. View

Li Z, Metze D, Nashan D, Muller-Tidow C, Serve H, Poremba C . Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Invest Dermatol. 2004; 123(4):737-45. DOI: 10.1111/j.0022-202X.2004.23408.x. View

Hussain S, Singh N, Salam I, Bandil K, Yuvaraj M, Bhat M . Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. J Recept Signal Transduct Res. 2011; 31(2):147-56. DOI: 10.3109/10799893.2011.553836. View

Wu Q, Zhu Y, Liu Y, Wei F, Tong Y, Cao J . CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia. Cell Death Dis. 2018; 9(7):774. PMC: 6039501. DOI: 10.1038/s41419-018-0812-6. View

Hanada T, Tanaka K, Matsumura Y, Yamauchi M, Nishinakamura H, Aburatani H . Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol. 2005; 174(7):4325-32. DOI: 10.4049/jimmunol.174.7.4325. View

Sporri B, Kovanen P, Sasaki A, Yoshimura A, Leonard W . JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood. 2001; 97(1):221-6. DOI: 10.1182/blood.v97.1.221. View

Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S . Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer. 2007; 97(9):1260-5. PMC: 2360457. DOI: 10.1038/sj.bjc.6604016. View

Chu P, Yeh C, Hsu N, Chang Y, Chang J, Yeh K . Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma. Swiss Med Wkly. 2010; 140:w13065. DOI: 10.4414/smw.2010.13065. View

Wu L, Zhang F, Zhou L, Yang Z, Xie H, Zheng S . Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation. BMC Cancer. 2010; 10:399. PMC: 2922195. DOI: 10.1186/1471-2407-10-399. View

10.

. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm. 1995; 45(1):13-26. View

11.

Toniato E, Chen X, Losman J, Flati V, Donahue L, Rothman P . TRIM8/GERP RING finger protein interacts with SOCS-1. J Biol Chem. 2002; 277(40):37315-22. DOI: 10.1074/jbc.M205900200. View

12.

Hashimoto M, Ayada T, Kinjyo I, Hiwatashi K, Yoshida H, Okada Y . Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. Cancer Sci. 2009; 100(4):730-6. PMC: 11159406. DOI: 10.1111/j.1349-7006.2009.01098.x. View

13.

Linossi E, Babon J, Hilton D, Nicholson S . Suppression of cytokine signaling: the SOCS perspective. Cytokine Growth Factor Rev. 2013; 24(3):241-8. PMC: 3816980. DOI: 10.1016/j.cytogfr.2013.03.005. View

14.

Sobti R, Singh N, Hussain S, Suri V, Nijhawan R, Bharti A . Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis. Cell Oncol (Dordr). 2011; 34(6):533-43. DOI: 10.1007/s13402-011-0056-2. View

15.

Babon J, McManus E, Yao S, DeSouza D, Mielke L, Sprigg N . The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. Mol Cell. 2006; 22(2):205-16. DOI: 10.1016/j.molcel.2006.03.024. View

16.

Lesinski G, Zimmerer J, Kreiner M, Trefry J, Bill M, Young G . Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer. 2010; 10:142. PMC: 2858748. DOI: 10.1186/1471-2407-10-142. View

17.

Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

18.

Frantsve J, Schwaller J, Sternberg D, Kutok J, Gilliland D . Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol Cell Biol. 2001; 21(10):3547-57. PMC: 100276. DOI: 10.1128/MCB.21.10.3547-3557.2001. View

19.

Starr R, Fuchsberger M, Lau L, Uldrich A, Goradia A, Willson T . SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo. J Immunol. 2009; 183(7):4537-44. DOI: 10.4049/jimmunol.0901010. View

20.

Evel-Kabler K, Song X, Aldrich M, Huang X, Chen S . SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest. 2005; 116(1):90-100. PMC: 1312019. DOI: 10.1172/JCI26169. View